loader from loading.io
🌱 Slow Starts, Strong Finishes: How Legends Are Really Made show art 🌱 Slow Starts, Strong Finishes: How Legends Are Really Made

Dr. Baliga's 'Podkasts for Curious Docs'

🏆 How do world-class performers really develop? A fascinating Science review (Güllich et al., 2025) overturns a deeply held belief: early stars are rarely future legends. Across sports, science, music, and chess, peak performers often showed slower early progress, less early specialization, and more multidisciplinary practice.   The lesson is lyrical in its simplicity: breadth before depth, patience before acceleration. For educators, mentors, and institutions, this challenges how we identify talent and design training—short-term brilliance may come at the cost of long-term...

info_outline
Aerobic Activity as Precision Cancer Prevention 🏃‍♀️🎯🧬 show art Aerobic Activity as Precision Cancer Prevention 🏃‍♀️🎯🧬

Dr. Baliga's 'Podkasts for Curious Docs'

🏃‍♀️ Exercise is not lifestyle advice—it’s cancer biology.   A landmark analysis of 443,768 adults from the UK Biobank and NHANES shows that regular aerobic physical activity (≈117–500 min/week) is associated with: • 21% lower risk of inflammation-related cancers • 34% lower all-cancer mortality   Mechanistically, exercise: 🔬 Reduces chronic low-grade inflammation 🧬 Reverses immunosenescence (↓ Mki67⁺ immune cells) 🛡️ Expands functional innate and adaptive immunity   Strikingly, the mortality benefit rivals—or exceeds—that of many modern...

info_outline
EU SafeHearts Plan: 🧬💓 From Genes to Gyms, ❤️ Know Your Numbers, ❤️ Stronger Hearts, Smarter Europe, Healthier Lives show art EU SafeHearts Plan: 🧬💓 From Genes to Gyms, ❤️ Know Your Numbers, ❤️ Stronger Hearts, Smarter Europe, Healthier Lives

Dr. Baliga's 'Podkasts for Curious Docs'

🫀 Europe puts the heart first.   The EU Safe Hearts Plan is a bold, evidence-based roadmap to tackle Europe’s leading cause of death—cardiovascular disease—through prevention 🛡️, early detection 🔍, better treatment 🏥, smart digital tools 🤖, and a relentless focus on equity ⚖️.   With clear targets (including a 25% reduction in premature cardiovascular mortality by 2035 🎯), this plan signals a shift from reactive care to lifelong, personalized, and data-driven heart health—for every citizen, in every region.   Strong hearts. Smarter systems. A...

info_outline
Hormones, and Abdominal Pain 🧬🦠🔥 How Estrogen Amplifies Gut Sensitivity in Females show art Hormones, and Abdominal Pain 🧬🦠🔥 How Estrogen Amplifies Gut Sensitivity in Females

Dr. Baliga's 'Podkasts for Curious Docs'

🧠🦠 Why does abdominal pain affect women more? Science offers a cellular answer.   A new Science study uncovers an estrogen-tuned gut pain circuit in which peptide YY–secreting enteroendocrine cells activate serotonin-releasing cells, sensitizing gut sensory nerves—especially in females. Hormones, microbes, and diet converge locally in the colon to amplify visceral pain, offering a biologically grounded explanation for menstrual-cycle variability and female-predominant disorders like irritable bowel syndrome.   📖 Venkataraman et al., Science (Dec 2025) Precision medicine...

info_outline
 Dr RR Baliga's Philosophical Discourses: Søren Kierkegaard (Denmark, 1813–1855 CE) – Existentialism show art Dr RR Baliga's Philosophical Discourses: Søren Kierkegaard (Denmark, 1813–1855 CE) – Existentialism

Dr. Baliga's 'Podkasts for Curious Docs'

📚🇩🇰 Søren Kierkegaard (1813–1855): the philosopher of choice, anxiety, and becoming Kierkegaard argued that the highest human task isn’t just knowing the good—it’s embodying it: becoming a self through commitment, responsibility, and inwardness. His framing of “existence” as the lived work of becoming helped spark what we now call existentialism. 🧭✨    In health care, his lens feels especially modern: moral distress, burnout, and “decision-fatigue” often intensify when we drift into autopilot—or when we outsource conscience to the “crowd.”...

info_outline
A Molecular Autopsy in Real Time 🧬⏱️Checkpoint Inhibitors, Multiorgan Damage ♟️🧬⚠️ show art A Molecular Autopsy in Real Time 🧬⏱️Checkpoint Inhibitors, Multiorgan Damage ♟️🧬⚠️

Dr. Baliga's 'Podkasts for Curious Docs'

🧬 When immunity saves—and harms—at the same time   A striking NEJM correspondence reveals that patients receiving immune checkpoint inhibitors often sustain molecularly detectable multiorgan damage—weeks to months before symptoms appear. Using cell-free DNA methylation mapping, investigators show that immune-related adverse events are systemic, not isolated organ toxicities—the visible clinic finding is just the tip of the iceberg 🧊🧬   This work reframes irAEs as a global loss of immune tolerance and opens the door to early, molecular surveillance—particularly...

info_outline
Same Drink, Worse Morning 🍷⏳😖Alcohol vs the Aging Clock ⏰🍸😴 show art Same Drink, Worse Morning 🍷⏳😖Alcohol vs the Aging Clock ⏰🍸😴

Dr. Baliga's 'Podkasts for Curious Docs'

🍷⏳ Why Hangovers Get Worse as We Age — Science, Not Sentiment   Ever wondered why the same drink that once sparkled now punishes? A Well Informed piece from The Economist explains how aging physiology—less body water, slower metabolism, disrupted sleep, and toxic metabolites—turns modest indulgence into a morning reckoning. 🧠💤☠️   The takeaway is not abstinence, but wisdom: sip slowly, hydrate deliberately, respect sleep, and never underestimate biology. Aging, like good scholarship, rewards those who read the fine print. 📖🍸

info_outline
⏳➡️⏰ Can Science Make Old Immune Cells Young Again? show art ⏳➡️⏰ Can Science Make Old Immune Cells Young Again?

Dr. Baliga's 'Podkasts for Curious Docs'

🧬✨ Can we make the ageing immune system young again? A fascinating Nature study shows that a three-part mRNA cocktail (DFI) can temporarily rejuvenate T cells in aged mice, improving responses to vaccines and cancer immunotherapy—without breaking immune tolerance. By turning the liver into a short-term factory for key immune signals (DLL1, FLT3L, IL-7), the authors demonstrate that immune ageing is modifiable, not fixed. This elegant work—covered by Heidi Ledford in —opens provocative questions about immune resilience, ageing biology, and the future of mRNA beyond vaccines....

info_outline
Protein Moderation: Age Slower, Live Better 🧬⏳❤️ show art Protein Moderation: Age Slower, Live Better 🧬⏳❤️

Dr. Baliga's 'Podkasts for Curious Docs'

🧬 Protein Restriction, Aging, and Longevity ⏳   A remarkable new study in Cell shows that moderate protein restriction—especially when started in midlife—can reprogram aging biology across 41 organs, improving metabolic and cardiovascular health. 🫀⚙️   Using deep multi-organ proteomics in mice and human plasma validation, the authors demonstrate benefits mediated through ↓ IGF-1, ↓ mTOR, ↑ AMPK, and activation of brown adipose tissue. Importantly, the data also caution that extreme protein restriction may provoke inflammation, underscoring that moderation...

info_outline
Waves, Not Lone Rangers 🌊⚔️🧬: How Neutrophils Work Collectively show art Waves, Not Lone Rangers 🌊⚔️🧬: How Neutrophils Work Collectively

Dr. Baliga's 'Podkasts for Curious Docs'

🧬 Rethinking Neutrophils: From Lone Cells to Living Systems 🧠⚔️   For over a century, neutrophils were seen as short-lived foot soldiers of immunity. This new Cell review reframes them as something far more interesting: a coordinated, adaptive collective.   ✨ Key ideas: • Short-lived cells, long-term memory • Two compartments: granulopoietic + mature • Plastic, circadian, tissue-adaptive behavior • Major implications for inflammation, cancer, and immunotherapy   A powerful example of how systems thinking can transform classical immunology.   📖 Worth a...

info_outline
 
More Episodes

Coronary CT angiography-guided management of patients
with stable chest pain: 10-year outcomes from the SCOT-
HEART randomised controlled trial in Scotland


Michelle C Williams, Ryan Wereski, Christopher Tuck, Philip D Adamson, Anoop S V Shah, Edwin J R van Beek, Giles Roditi, Colin Berry,Nicholas Boon, Marcus Flather, Steff Lewis, John Norrie, Adam D Timmis, Nicholas L Mills, Marc R Dweck, David E Newby, on behalf of theSCOT-HEART Investigators*


Summary
Background The Scottish Computed Tomography of the Heart (SCOT-HEART) trial demonstrated that management
guided by coronary CT angiography (CCTA) improved the diagnosis, management, and outcome of patients with
stable chest pain. We aimed to assess whether CCTA-guided care results in sustained long-term improvements in
management and outcomes.


Methods SCOT-HEART was an open-label, multicentre, parallel group trial for which patients were recruited from
12 outpatient cardiology chest pain clinics across Scotland. Eligible patients were aged 18–75 years with symptoms of
suspected stable angina due to coronary heart disease. Patients were randomly assigned (1:1) to standard of care plus
CCTA or standard of care alone. In this prespecified 10-year analysis, prescribing data, coronary procedural
interventions, and clinical outcomes were obtained through record linkage from national registries. The primary
outcome was coronary heart disease death or non-fatal myocardial infarction on an intention-to-treat basis. This trial
is registered at ClinicalTrials.gov (NCT01149590) and is complete.


Findings Between Nov 18, 2010, and Sept 24, 2014, 4146 patients were recruited (mean age 57 years [SD 10], 2325 [56·1%] male, 1821 [43·9%] female), with 2073 randomly assigned to standard care and CCTA and 2073 to standard care
alone. After a median of 10·0 years (IQR 9·3–11·0), coronary heart disease death or non-fatal myocardial infarction
was less frequent in the CCTA group compared with the standard care group (137 [6·6%] vs 171 [8·2%]; hazard ratio
[HR] 0·79 [95% CI 0·63–0·99], p=0·044). Rates of all-cause, cardiovascular, and coronary heart disease death, and
non-fatal stroke, were similar between the groups (p>0·05 for all), but non-fatal myocardial infarctions (90 [4·3%] vs
124 [6·0%]; HR 0·72 [0·55–0·94], p=0·017) and major adverse cardiovascular events (172 [8·3%] vs 214 [10·3%];
HR 0·80 [0·65–0·97], p=0·026) were less frequent in the CCTA group. Rates of coronary revascularisation procedures
were similar (315 [15·2%] vs 318 [15·3%]; HR 1·00 [0·86–1·17], p=0·99) but preventive therapy prescribing remained
more frequent in the CCTA group (831 [55·9%] of 1486 vs 728 [49·0%] of 1485 patients with available data; odds ratio
1·17 [95% CI 1·01–1·36], p=0·034).


Interpretation After 10 years, CCTA-guided management of patients with stable chest pain was associated with a
sustained reduction in coronary heart disease death or non-fatal myocardial infarction. Identification of coronary
atherosclerosis by CCTA improves long-term cardiovascular disease prevention in patients with stable chest pain.